Juno halts midstage drug study over deaths

Friday, July 8, 2016 - 07:11 in Health & Medicine

NEW YORK (AP) -- Shares of Juno Therapeutics plunged Friday after halting a midstage study on a potential leukemia treatment following two patient deaths....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net